Cardiac amyloidosis: Treatment and prognosis - UpToDate Amyloid deposits can occur in a variety of organs, but morbidity and mortality from amyloid deposition most commonly occur when the heart, kidney, liver, or autonomic nervous system are affected (See "Overview of amyloidosis" ) This topic will review the treatment and prognosis of cardiac amyloidosis
Cardiac Amyloidosis Clinic - Overview - Mayo Clinic A team approach At the Cardiac Amyloidosis Clinic, doctors who specialize in blood conditions (hematologists), the heart (cardiologists), imaging (radiologists), anatomic pathology, computational biology, neurology, nephrology and hypertension, and other areas work together to provide excellent, comprehensive care
FOCUS on Cardiac Amyloidosis - European Society of Cardiology Cardiac amyloidosis is a progressive disease caused by the extracellular deposition of amyloid fibrils in the heart More frequent than previously believed, it contributes to many common clinical scenarios such as severe aortic stenosis, increased left ventricular wall thickness and heart failure with preserved ejection fraction
Heart Failure Management of Patients with Amyloid . . . Abstract Cardiac amyloidosis (CA) can lead to progressive heart failure (HF) by depositing insoluble amyloid fibrils within the myocardial extracellular space, resulting in an infiltrative and restrictive cardiomyopathy Although CA was previously perceived as rare and incurable, recent advances in diagnostics and emerging therapies have been changing this outlook It is crucial to spread
Cardiac Amyloidosis - Johns Hopkins Medicine What are the symptoms of cardiac amyloidosis? Symptoms of AL and ATTR amyloidosis are determined by the organs involved in the disease In cardiac amyloidosis, amyloid protein deposits in the heart muscle causes it to become thick and stiffened Over time, this can cause the heart to become weak Amyloid protein deposits in the heart can lead to: Congestive heart failure Symptoms include